Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.LFWD · Entity 7620 | Chief Medical Officer | May 01, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date May 01, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, no par value per shareSEC Table I · non-derivative | Direct | 17,083 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 15,000 · Balance 17,083 F1: Represents 15,000 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on May 1, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments commencing from the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 15,000 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on May 1, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments commencing from the Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 20, 2026 12:15 UTC | Lifeward Ltd. LFWD · Entity 7620 | GrantOrdinary Shares, no par value per share | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002845 · ownership.xml · nonDerivative · entry 1 Rose Keith Dale · CIK 0002136050 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,083 F1 · shares: Represents 15,000 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on May 1, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments commencing from the Grant Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.